| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Endocrinology |
Departments of 1 Physiological Chemistry, 2 Internal Medicine and Endocrinology, and 3 Metabolic and Endocrine Diseases, University Medical Center Utrecht, Utrecht, the Netherlands
Requests for reprints: H.Th. Marc Timmers, Department of Physiological Chemistry, University Medical Center Utrecht, Universiteitsweg 100, 3508 AB Utrecht, the Netherlands. Phone: 31-30-253-8981; Fax: 31-30-253-9035; E-mail: h.t.m.timmers{at}med.uu.nl.
The product of the multiple endocrine neoplasia type 1 (MEN1) tumor suppressor gene, menin, is an integral component of MLL1/MLL2 histone methyltransferase complexes specific for Lys4 of histone H3 (H3K4). We show that menin is a transcriptional coactivator of the nuclear receptors for estrogen and vitamin D. Activation of the endogenous estrogen-responsive TFF1 (pS2) gene results in promoter recruitment of menin and in elevated trimethylation of H3K4. Knockdown of menin reduces both activated TFF1 (pS2) transcription and H3K4 trimethylation. In addition, menin can directly interact with the estrogen receptor-
(ER
) in a hormone-dependent manner. The majority of disease-related MEN1 mutations prevent menin-ER
interaction. Importantly, ER
-interacting mutants are also defective in coactivator function. Our results indicate that menin is a critical link between recruitment of histone methyltransferase complexes and nuclear receptormediated transcription. (Cancer Res 2006; 66(9): 4929-35)
This article has been cited by other articles:
![]() |
S. Lee, J. Lee, S.-K. Lee, and J. W. Lee Activating Signal Cointegrator-2 Is an Essential Adaptor to Recruit Histone H3 Lysine 4 Methyltransferases MLL3 and MLL4 to the Liver X Receptors Mol. Endocrinol., June 1, 2008; 22(6): 1312 - 1319. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Hussein, J. Lu, H. Casse, S. Fontaniere, A.-M. Morera, S. M. Guittot, A. Calender, N. Di Clemente, and C. X Zhang Deregulation of anti-Mullerian hormone/BMP and transforming growth factor-{beta} pathways in Leydig cell lesions developed in male heterozygous multiple endocrine neoplasia type 1 mutant mice Endocr. Relat. Cancer, March 1, 2008; 15(1): 217 - 227. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Matoso, Z. Zhou, R. Hayama, A. Flesken-Nikitin, and A. Yu. Nikitin Cell lineage-specific interactions between Men1 and Rb in neuroendocrine neoplasia Carcinogenesis, March 1, 2008; 29(3): 620 - 628. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. La, Y. Yang, S. K. Karnik, A. C. Silva, R. W. Schnepp, S. K. Kim, and X. Hua Menin-mediated Caspase 8 Expression in Suppressing Multiple Endocrine Neoplasia Type 1 J. Biol. Chem., October 26, 2007; 282(43): 31332 - 31340. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E LEADER, C. WANG, V. M POPOV, M. FU, and R. G PESTELL Epigenetics and the Estrogen Receptor Ann. N.Y. Acad. Sci., November 1, 2006; 1089(1): 73 - 87. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Lee, D.-K. Lee, Y. Dou, J. Lee, B. Lee, E. Kwak, Y.-Y. Kong, S.-K. Lee, R. G. Roeder, and J. W. Lee Coactivator as a target gene specificity determinant for histone H3 lysine 4 methyltransferases PNAS, October 17, 2006; 103(42): 15392 - 15397. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |